New assessment tool for evaluating memory in Alzheimer's patients
Development, Standardisation and Standardisation Project for a New Memory Assessment
This study is testing a new memory tool for people with Alzheimer's to see if it can better understand their memory issues compared to traditional methods.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 150 (estimated) |
| Ages | 50 Years and up |
| Sex | All |
| Sponsor | University Hospital, Tours Academic / other |
| Locations | 1 site (Tours) |
| Trial ID | NCT06564779 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate a new tool called the New Evaluation of Episodic Memory (NEM) designed to assess episodic memory in patients with Alzheimer's disease. The NEM incorporates emotional and identity aspects of memory, which are often overlooked in traditional assessments. By analyzing response profiles from patients, the study seeks to determine the tool's effectiveness in differentiating Alzheimer's disease from other memory disorders. Participants will be assessed based on specific eligibility criteria, including age and cognitive profile.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 50 and older with an amnesic mild cognitive impairment profile.
Not a fit: Patients with severe sensory impairments or those unable to participate in neuropsychological assessments may not benefit from this study.
Why it matters
Potential benefit: If successful, this assessment tool could lead to more accurate diagnoses of Alzheimer's disease and improve patient care.
How similar studies have performed: Preliminary studies have shown promise for similar approaches, indicating potential for success in this novel assessment method.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 50 years * Ability to understand judged sufficient by the assessor; * Amnesic MCI profile (Petersen, 2003) during the 1st medical consultation prior to the assessment being prescribed. Exclusion Criteria: * Severe auditory and/or visual sensory impairment not compatible with neuropsychological assessment; * Judged fit to take the test by the assessor; * Patient under guardianship, curatorship or family guardianship; * Opposition to data processing.
Where this trial is running
Tours
- University hospital — Tours, France (Recruiting)
Study contacts
- Principal investigator: Alix LAUNAY — Tours University Hospital
- Study coordinator: Alix LAUNAY
- Email: a.launay@chu-tours.fr
- Phone: 0247470458
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.